OTCPK:OMCM

Stock Analysis Report

Executive Summary

OmniComm Systems, Inc., a healthcare technology company, provides Web-based electronic data capture (EDC), and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors worldwide.

Snowflake

Fundamentals

Imperfect balance sheet with weak fundamentals.

Risks

  • OmniComm Systems has significant price volatility in the past 3 months.
  • OmniComm Systems is not covered by any analysts.

Similar Companies

Share Price & News

How has OmniComm Systems's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.01%

OTCPK:OMCM

-0.003%

US Healthcare Services

-0.02%

US Market


1 Year Return

4.9%

OTCPK:OMCM

8.6%

US Healthcare Services

1.6%

US Market

OMCM underperformed the Healthcare Services industry which returned 9.4% over the past year.

OMCM outperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

OMCMIndustryMarket
7 Day0.01%-0.003%-0.02%
30 Day1.0%-5.0%2.7%
90 Day48.8%-5.6%1.4%
1 Year4.9%4.9%8.7%8.6%3.8%1.6%
3 Year86.0%86.0%49.3%49.0%45.2%35.8%
5 Year184.2%184.2%49.4%48.5%61.8%44.1%

Price Volatility Vs. Market

How volatile is OmniComm Systems's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is OmniComm Systems undervalued based on future cash flows and its price relative to the stock market?


Intrinsic Value Based on Future Cash Flows

OmniComm Systems's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

OmniComm Systems's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

OmniComm Systems is loss making, we can't compare its value to the US Healthcare Services industry average.

OmniComm Systems is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for OmniComm Systems, we can't assess if its growth is good value.


Price Based on Value of Assets

OmniComm Systems has negative assets, we can't compare the value of its assets to the US Healthcare Services industry average.


Next Steps

Future Growth

How is OmniComm Systems expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as OmniComm Systems has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of OMCM’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access OmniComm Systems's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has OmniComm Systems performed over the past 5 years?

30.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

OmniComm Systems does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare OmniComm Systems's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare OmniComm Systems's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if OmniComm Systems has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

OmniComm Systems used its assets less efficiently than the US Healthcare Services industry average last year based on Return on Assets.


Return on Capital Employed

It is difficult to establish if OmniComm Systems improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is OmniComm Systems's financial position?


Financial Position Analysis

OmniComm Systems's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

OmniComm Systems's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

OmniComm Systems has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if OmniComm Systems's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

OmniComm Systems has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Whilst loss making OmniComm Systems has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.

Whilst loss making OmniComm Systems has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 23% per year.


Next Steps

Dividend

What is OmniComm Systems's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate OmniComm Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate OmniComm Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as OmniComm Systems has not reported any payouts.

Unable to verify if OmniComm Systems's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as OmniComm Systems has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of OmniComm Systems's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average management tenure


CEO

Steve Johnson (54yo)

2.3yrs

Tenure

US$426,462

Compensation

Mr. Stephen E. Johnson, also known as Steve, has been the Chief Executive Officer and President and of OmniComm Systems Inc. since June 1, 2017 and since June 1, 2010 respectively and served as its Chief O ...


CEO Compensation Analysis

Steve's remuneration is about average for companies of similar size in United States of America.

Steve's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.3yrs

Average Tenure

56yo

Average Age

The tenure for the OmniComm Systems management team is about average.


Board Age and Tenure

3.9yrs

Average Tenure

66yo

Average Age

The tenure for the OmniComm Systems board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Randy Smith (61yo)

    Founder & Executive Vice Chairman

    • Tenure: 2.3yrs
  • Cees Wit (72yo)

    Executive Chairman

    • Tenure: 2.3yrs
    • Compensation: US$84.00k
  • Keith Howells (64yo)

    Chief Technology Officer

    • Tenure: 2.3yrs
  • Steve Johnson (54yo)

    President & CEO

    • Tenure: 2.3yrs
    • Compensation: US$426.46k
  • Ken Light

    Executive Vice President of Corporate Strategy

    • Tenure: 12.3yrs
  • Yvonne Rollinger

    Managing Director of OmniComm Europe GmbH

    • Tenure: 0yrs
  • Tom Vickers (56yo)

    Chief Financial Officer

    • Tenure: 6.9yrs
  • Kuno van der Post (51yo)

    Chief Commercial Officer

    • Tenure: 2.3yrs
    • Compensation: US$461.62k
  • John Fontenault (53yo)

    Chief Operating Officer

    • Tenure: 2.3yrs
  • Kim Rejndrup

    Senior Vice President of Product Development

    • Tenure: 1.9yrs

Board Members

  • Randy Smith (61yo)

    Founder & Executive Vice Chairman

    • Tenure: 2.3yrs
  • Cees Wit (72yo)

    Executive Chairman

    • Tenure: 2.3yrs
    • Compensation: US$84.00k
  • Bob Schweitzer (73yo)

    Lead Independent Director

    • Tenure: 3.9yrs
    • Compensation: US$84.00k
  • Gary Shangold (65yo)

    Independent Director

    • Tenure: 5.2yrs
    • Compensation: US$78.00k
  • Adam Cohen (66yo)

    Independent Director

    • Tenure: 5.8yrs
    • Compensation: US$78.00k

Company Information

OmniComm Systems, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: OmniComm Systems, Inc.
  • Ticker: OMCM
  • Exchange: OTCPK
  • Founded: 1996
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$65.919m
  • Shares outstanding: 161.09m
  • Website: https://www.omnicomm.com

Number of Employees


Location

  • OmniComm Systems, Inc.
  • 2101 West Commercial Boulevard
  • Suite 3500
  • Fort Lauderdale
  • Florida
  • 33309
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
OMCMOTCPK (Pink Sheets LLC)YesCommon StockUSUSDDec 1999

Biography

OmniComm Systems, Inc., a healthcare technology company, provides Web-based electronic data capture (EDC), and eClinical software and services for pharmaceutical and biotechnology companies, clinical resea ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 23:38
End of Day Share Price2019/09/12 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.